Chemotherapy of head and neck cancerISCOE, N.Clinics in oncology. 1986, Vol 5, Num 3, pp 575-593, issn 0261-9873Article

A phase II study of methotrexate, vinblastine, doxorubicin and cisplatin plus recombinant human granulocyte-macrophage colony stimulating factors in patients with advanced transitional cell carcinomaMOORE, M. J; ISCOE, N; TANNOCK, I. F et al.The Journal of urology. 1993, Vol 150, Num 4, pp 1131-1134, issn 0022-5347Article

A field study of the software design process for large systemsCURTIS, B; KRASNER, H; ISCOE, N et al.Communications of the ACM. 1988, Vol 31, Num 11, pp 1268-1287, issn 0001-0782Article

Predictive value of staging investigations in patients with clinical stage I malignant melanoma. DiscussionISCOE, N; KERSEY, P; GAPSKI, J et al.Plastic and reconstructive surgery (1963). 1987, Vol 80, Num 2, pp 233-239, issn 0032-1052Article

The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphineDESCHAMPS, M; BAND, P. R; HISLOP, T. G et al.Journal of pain and symptom management. 1992, Vol 7, Num 7, pp 384-392, issn 0885-3924Article

Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatientsKERR, I. G; SONE, M; DEANGELIS, C et al.Annals of internal medicine. 1988, Vol 108, Num 4, pp 554-557, issn 0003-4819Article

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerCULLEN, M. H; ZATLOUKAL, P; SÖRENSON, S et al.Annals of oncology. 2008, Vol 19, Num 5, pp 939-945, issn 0923-7534, 7 p.Article

Predicting psychological distress in patients with cancer : conceptual basis and reliability evaluation of a self-report questionnaireFITCH, M. I; OSOBA, D; ISCOE, N et al.Anticancer research. 1995, Vol 15, Num 4, pp 1533-1542, issn 0250-7005Article

Lomustine, vincristine, and procarbazine in the treatment of metastatic malignat melanomaSHELLEY, W; QUIRT, I; BODURTHA, A et al.Cancer treatment reports. 1985, Vol 69, Num 9, pp 941-944, issn 0361-5960Article

Observer error in the characterization of hepatic lesions in patients with neoplastic liver diseaseISCOE, N. A; MCKEE, J. D; ARENSON, A. M et al.Journal of clinical ultrasound. 1988, Vol 16, Num 8, pp 577-579, issn 0091-2751Article

A phase II study of weekly edatreate (10-EDAM) in metastatic melanoma: a national cancer institute of Canada clinical trials groups studyVERMA, S; QUIRT, I. C; EISENHAUER, E. A et al.Annals of oncology. 1993, Vol 4, Num 3, pp 254-255, issn 0923-7534Article

Prostate cancer screening in the midst of controversy : Canadian men's knowledge, beliefs, utilization, and future intentionsMERCER, S. L; GOEL, V; LEVY, I. G et al.Canadian journal of public health. 1997, Vol 88, Num 5, pp 327-332, issn 0008-4263Article

The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanomaKERSEY, P. A; ISCOE, N. A; GAPSKI, J. A. P et al.British journal of surgery. 1985, Vol 72, Num 8, pp 614-617, issn 0007-1323Article

Extragonadal germ cell tumors : a 14-year Toronto experienceGOSS, P. E; SCHWERTFEGER, L; BLACKSTEIN, M. E et al.Cancer. 1994, Vol 73, Num 7, pp 1971-1979, issn 0008-543XArticle

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanomaRUSTHOVEN, J. J; QUIRT, I. C; VERMA, S et al.Journal of clinical oncology. 1996, Vol 14, Num 7, pp 2083-2090, issn 0732-183XArticle